Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

After offering a deep dive last year into the recipe behind its lead lung fibrosis candidate, Insilico Medicine is now giving ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...